Drug:
Reaction: COUGH
20260101 - 20261231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 26913495 |
CL |
62 | 2 |
Blood pressure increased, Feeling abnormal, Fall, Anxiety, Epilepsy, Ankle fracture, Migraine, Bradycardia, Hypotension, Amnesia, Blood creatinine increased, Vomiting, Nausea, Hypertension, Diarrhoea, C-reactive protein abnormal, Blood urea abnormal, Blood cholesterol abnormal, International normalised ratio abnormal, Blood potassium abnormal, Insomnia, Foot fracture, Blood alkaline phosphatase increased, Dizziness, Haematocrit decreased, Haemoglobin decreased, White blood cell count decreased, Malaise, Headache, Abnormal behaviour, Emotional distress, Skin discolouration, Depression, Ligament sprain, Myopia, Contusion, Wound, Pain, Keratitis, Thrombosis, Metastases to bone, Loss of consciousness, Asphyxia, Choking, Petit mal epilepsy, Metastases to lung, Neoplasm malignant, Neutrophil count decreased, Tinnitus, Immunodeficiency, Eye swelling, Pulmonary pain, Depressed mood, Nasal ulcer, Noninfective gingivitis, Gingival erythema, Aphthous ulcer, Weight increased, Morton^s neuralgia, Hypoglycaemia, Food intolerance, Scab, Epistaxis, Nasal injury, Gait disturbance, Ageusia, Visual impairment, Musculoskeletal chest pain, General physical health deterioration, Electric shock sensation, Full blood count decreased, Influenza, Productive cough, Cough, Pharyngitis, Haemoptysis, Pain, Fluid retention, Fat tissue increased, Dry eye, Back pain, Abdominal discomfort, Diarrhoea, Fatigue, Headache, Dysgeusia, Memory impairment, Aversion, Blood sodium increased, Eye pain, Yawning, Eyelid margin crusting, Eye disorder, Swelling, Nervousness, Anisocytosis, Poikilocytosis, Polychromasia, Macrocytosis, Elliptocytosis, Discomfort, Atrioventricular block first degree, Red cell distribution width increased, Red blood cell sedimentation rate increased, Blood glucose increased, Gastrointestinal disorder, Mean cell volume increased, Rouleaux formation, Limb deformity, Oral herpes, Ill-defined disorder, Thyroid mass, Visual impairment, Decreased immune responsiveness, Neoplasm, Arthritis, Gingival disorder, Pruritus, Hypersensitivity, Pyrexia, Red blood cell count decreased, Lymphocyte count decreased, Dry skin, Pain in extremity, Vision blurred, Herpes virus infection, Viral diarrhoea, Colitis, Chills, Agitation, Confusional state, Oesophagitis, Gastrooesophageal reflux disease, Stress, Catheter site pain, High density lipoprotein abnormal, Gait inability, Mobility decreased, Diplopia, Impaired healing, Weight decreased, Nasopharyngitis, Alopecia, Tension headache, |
||||
LETROZOLE, LETROZOLE, LETROZOLE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LANSOPRAZOLE, ERGOCALCIFEROL, CALCIUM, |
||||
| 402 | 26913541 |
AU |
80 | 2 |
Cataract operation, Oropharyngeal pain, Off label use, Cough, Dyspnoea, |
||||
| 403 | 26913769 |
BR |
63 | 2 |
Acute myeloid leukaemia, Second primary malignancy, Septic shock, Somnolence, Pyrexia, Hypotension, Chills, Dyspnoea, Multiple organ dysfunction syndrome, Nervous system disorder, Cardiovascular disorder, Renal impairment, Hepatic function abnormal, Neutrophil count decreased, Cytokine release syndrome, Pyrexia, Hypotension, Febrile neutropenia, Febrile neutropenia, Pyrexia, Leukopenia, Haemoglobin decreased, Thrombocytopenia, Pneumonia, Skin reaction, Wheezing, Haemorrhage, Cough, Hyperaemia, Pruritus, Purpura, Contusion, Pancytopenia, Platelet count decreased, Lymphocyte count decreased, Vitreous haemorrhage, Acute kidney injury, Blood alkaline phosphatase increased, Blood urea increased, Eosinophil count decreased, Monocyte count decreased, White blood cell count decreased, Serum ferritin increased, Fibrin D dimer increased, Nausea, Vomiting, Pain in extremity, Tremor, Somnolence, Constipation, Fatigue, Oedema peripheral, Gingival bleeding, Hepatic mass, Odynophagia, Back pain, Erythema, Petechiae, Asthenia, Headache, Epistaxis, Pain in extremity, Paraesthesia, Pain in extremity, Dry mouth, |
||||
TISAGENLECLEUCEL, CEFEPIME HYDROCHLORIDE, CEFEPIME, MEROPENEM, |
||||
| 404 | 26913843 |
US |
1 | |
Cough, Illness, Nasal congestion, Oropharyngeal pain, |
||||
SIBEPRENLIMAB, |
||||
| 405 | 26913875 |
US |
61 | 2 |
Fatigue, Chest discomfort, Cough, |
||||
SIBEPRENLIMAB, |
||||
| 406 | 26913889 |
US |
1 | |
Nasopharyngitis, Cough, |
||||
SIBEPRENLIMAB, |
||||
| 407 | 26913900 |
US |
2 | |
Injection site pain, Respiratory disorder, Cough, |
||||
SIBEPRENLIMAB, SIBEPRENLIMAB, |
||||
| 408 | 26913904 |
US |
18 | 2 |
Cough, Pyrexia, Nasal congestion, |
||||
SIBEPRENLIMAB, |
||||
| 409 | 26914073 |
US |
2 | |
Influenza like illness, Cough, Injection site pain, Frequent bowel movements, |
||||
SIBEPRENLIMAB, |
||||
| 410 | 26914102 |
US |
2 | |
Tonsillar hypertrophy, Cough, Arthralgia, Peripheral swelling, Pain in extremity, |
||||
SIBEPRENLIMAB, |
||||
| 411 | 26914113 |
US |
41 | 2 |
Bone pain, Hypersensitivity, Pain, Pyrexia, Cough, Nasopharyngitis, |
||||
SIBEPRENLIMAB, |
||||
| 412 | 26914114 |
US |
2 | |
Rhinorrhoea, Cough, Adverse drug reaction, |
||||
SIBEPRENLIMAB, |
||||
| 413 | 26914163 |
US |
30 | 1 |
Pyrexia, Sinus congestion, Oropharyngeal pain, Cough, Upper respiratory tract infection, |
||||
SIBEPRENLIMAB, SIBEPRENLIMAB, |
||||
| 414 | 26914480 |
US |
53 | 2 |
Choking, Cough, Medication error, Incorrect dose administered, |
||||
BRIMONIDINE TARTRATE, |
||||
| 415 | 26917078 |
2 | ||
Pneumonia, Aspergillus infection, Weight decreased, Nausea, Cough, |
||||
LENALIDOMIDE, ACYCLOVIR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, THIAMINE HYDROCHLORIDE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 416 | 26919100 |
58 | 2 | |
Tinnitus, Bone cancer, Cough, Lung neoplasm malignant, Blood pressure increased, |
||||
EVEROLIMUS, LENVATINIB, |
||||
| 417 | 26904650 |
US |
76 | 2 |
Cough, Pyrexia, Loss of consciousness, Head injury, |
||||
LENALIDOMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACYCLOVIR, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DIPHENHYDRAMINE HYDROCHLORIDE, CARVEDILOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DONEPEZIL HYDROCHLORIDE, DOXEPIN, DOXEPIN HYDROCHLORIDE, ACETAMINOPHEN, ASPRIN, CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID), AND CAFFEINE, ACETAMINOPHEN, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, ACETAMINOPHEN, CAFFEINE, FAMOTIDINE, FENOFIBRATE, FERROUS SULFATE, FEXOFENADINE, GLIPIZIDE, EMPAGLIFLOZIN, LATANOPROST, LISINOPRIL, MAGNESIUM OXIDE, MONTELUKAST, PIOGLITAZONE, TIZANIDINE, DULAGLUTIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 418 | 26904655 |
US |
62 | 2 |
Cough, Chest discomfort, |
||||
DUPILUMAB, |
||||
| 419 | 26904802 |
US |
67 | 1 |
Seasonal allergy, Incorrect product administration duration, Rhinorrhoea, Cough, |
||||
EMPAGLIFLOZIN, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN GLARGINE, INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, LOSARTAN POTASSIUM, LOSARTAN, TICAGRELOR, |
||||
| 420 | 26905020 |
CO |
75 | 2 |
Cough, Influenza, Therapy interrupted, Product dispensing issue, Off label use, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, LOSARTAN, |
||||
| 421 | 26905051 |
US |
88 | 1 |
Cough, Asthenia, Dehydration, Pyrexia, Oxygen therapy, |
||||
NINTEDANIB, |
||||
| 422 | 26905112 |
BR |
46 | 2 |
Disease progression, Cough, Product dose omission issue, Product leakage, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 423 | 26905279 |
CA |
46 | |
Chest discomfort, Wheezing, Dyspnoea, Weight decreased, Harvey-Bradshaw index increased, Migraine, Oropharyngeal discomfort, Cough, Erythema, Dizziness, Intentional product use issue, Off label use, Inappropriate schedule of product administration, Product dose omission issue, Intentional dose omission, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 424 | 26905306 |
CA |
1 | |
Cataract, Upper-airway cough syndrome, Cough, Nasopharyngitis, Nasal congestion, Intentional dose omission, |
||||
| 425 | 26905357 |
GB |
74 | 2 |
Cardiac failure, Hot flush, Pain in extremity, Electric shock sensation, Cough, |
||||
ETANERCEPT, |
||||
| 426 | 26905383 |
US |
53 | 2 |
Nasopharyngitis, Oropharyngeal pain, Cough, Pain, Lip swelling, Fatigue, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 427 | 26905402 |
US |
73 | 2 |
Dyspnoea, Chest discomfort, Fatigue, Cough, Chest pain, |
||||
DUPILUMAB, |
||||
| 428 | 26905597 |
PE |
70 | 2 |
Bronchiectasis, Cough, Lung disorder, |
||||
DENOSUMAB, |
||||
| 429 | 26905601 |
US |
76 | |
Bowel movement irregularity, Sneezing, Cough, Rhinorrhoea, Hiccups, |
||||
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, |
||||
| 430 | 26905714 |
US |
84 | 2 |
Fall, Dyspnoea, Confusional state, Chest pain, Delirium, Pulmonary oedema, Wheezing, Cough, Asthma, Dyspnoea, Sputum discoloured, Therapy interrupted, Asthenia, Fatigue, Oedema peripheral, Arthritis, Retinal disorder, Generalised oedema, Adverse drug reaction, Insomnia, Stasis dermatitis, |
||||
BENRALIZUMAB, BENRALIZUMAB, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, AMLODIPINE, APIXABAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZELASTINE, BACLOFEN, |
||||
| 431 | 26905993 |
US |
2 | |
Skin ulcer, Hypersensitivity, Pyrexia, Hyperhidrosis, Dyspnoea, Fatigue, Pain, Skin warm, Erythema, Pain of skin, Cough, Haemoptysis, Diarrhoea, Abdominal pain upper, Dysuria, Weight decreased, Drug ineffective, Memory impairment, |
||||
DUPILUMAB, PREDNISONE, ERGOCALCIFEROL, |
||||
| 432 | 26906030 |
US |
91 | 2 |
Hypersensitivity, Aphonia, Nasopharyngitis, Cough, Throat irritation, Drug ineffective, |
||||
SARILUMAB, |
||||
| 433 | 26906075 |
CA |
2 | |
Angina pectoris, Abdominal pain upper, Haemorrhage, Dyspnoea, Poor quality sleep, Asthenia, Vomiting, Loss of personal independence in daily activities, Nausea, Dizziness, Fatigue, Headache, Hypersensitivity, Cough, Off label use, Therapeutic response changed, |
||||
OMALIZUMAB, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 434 | 26906500 |
CO |
77 | 2 |
Memory impairment, COVID-19, Headache, Anxiety, Blister, Gastroenteritis viral, Psychiatric symptom, Pruritus, Urticaria, Illness, Bone disorder, Malaise, Cough, Gastrooesophageal reflux disease, Fall, Gait disturbance, Erythema, Dry skin, Angioedema, Swelling face, Peripheral swelling, Dyspnoea, Fatigue, Back pain, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FEXOFENADINE, |
||||
| 435 | 26906649 |
2 | ||
Drug ineffective, Cough, |
||||
LORATADINE, LORATADINE, |
||||
| 436 | 26906716 |
US |
58 | 1 |
Injection site pain, Dyspnoea, Cough, Product preparation issue, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 437 | 26906980 |
US |
||
Protein urine present, Cough, |
||||
ORAL SEMAGLUTIDE, LOSARTAN, |
||||
| 438 | 26907066 |
CA |
85 | |
Lower respiratory tract infection, Condition aggravated, Nasopharyngitis, Wheezing, Productive cough, Sputum discoloured, Cough, Therapy change, Product availability issue, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CICLESONIDE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CICLESONIDE, LATANOPROSTENE BUNOD, |
||||
| 439 | 26907070 |
US |
58 | 1 |
Cough, Arthralgia, |
||||
DUPILUMAB, |
||||
| 440 | 26907184 |
US |
53 | 1 |
Psoriatic arthropathy, Injection site pain, Cough, Pyrexia, Sinusitis, Nasopharyngitis, Drug ineffective, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, ROSUVASTATIN, LOSARTAN, PREDNISONE, |
||||
| 441 | 26907369 |
CO |
83 | 1 |
Death, Dyspnoea, Pleural effusion, Cough, Pulmonary hypertension, Hypoxia, |
||||
ENFORTUMAB VEDOTIN, PEMBROLIZUMAB, |
||||
| 442 | 26907410 |
US |
54 | 2 |
Cough, Wrong technique in device usage process, Incorrect dose administered by device, Product taste abnormal, Device delivery system issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE, BUDESONIDE AND FORMOTEROL FUMARATE, BUDESONIDE AND FORMOTEROL FUMARATE, BUDESONIDE AND FORMOTEROL FUMARATE, |
||||
| 443 | 26907414 |
CA |
2 | |
Pneumonia, Asthma, Cough, Dyspnoea, |
||||
TIOTROPIUM BROMIDE INHALATION SPRAY, ALBUTEROL SULFATE, MONTELUKAST SODIUM, |
||||
| 444 | 26907460 |
US |
36 | 2 |
Cough, Pulmonary congestion, Pyrexia, Infection, Infective pulmonary exacerbation of cystic fibrosis, Product dose omission issue, Socioeconomic precarity, Nasopharyngitis, |
||||
VANZACAFTOR, TEZACAFTOR, AND DEUTIVACAFTOR, LEVOTHYROXINE SODIUM, |
||||
| 445 | 26907506 |
1 | ||
Cough, Sinus disorder, Weight decreased, Hypersensitivity, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 446 | 26907546 |
US |
63 | 2 |
Cough, Secretion discharge, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 447 | 26907584 |
US |
2 | |
Pneumonia, Cough, |
||||
BIMEKIZUMAB, |
||||
| 448 | 26907739 |
CN |
||
Insomnia, Aspartate aminotransferase increased, Alanine aminotransferase increased, Gamma-glutamyltransferase increased, Coagulopathy, Vomiting, Nausea, Decreased appetite, Hypertension, Abdominal distension, Abdominal pain, Back pain, Cough, Asthma, Weight decreased, Rash, Hypothyroidism, Blood creatinine increased, Anaemia, Blood bilirubin increased, Pneumonia, Blood albumin decreased, Constipation, Pyrexia, Lymphopenia, Neutropenia, Thrombocytopenia, Fatigue, Hypoacusis, |
||||
CAPECITABINE, ATEZOLIZUMAB, DURVALUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, OXALIPLATIN, OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 449 | 26907838 |
US |
73 | 2 |
Respiratory syncytial virus infection, Cough, Nasal congestion, Nasopharyngitis, Respiratory tract infection, |
||||
DUPILUMAB, |
||||
| 450 | 26907913 |
EU |
9 | 1 |
Respiratory distress, Cough, Eyelid oedema, Lip oedema, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 451 | 26908271 |
US |
2 | |
Cough, Device malfunction, Insurance issue, Product delivery mechanism issue, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 452 | 26908480 |
US |
27 | |
Unevaluable event, Vomiting, Cough, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, TREPROSTINIL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PREDNISONE, OXYGEN, 0XYGEN, |
||||
| 453 | 26908482 |
US |
65 | |
Pneumonia, Rib fracture, Osteoporosis, Musculoskeletal chest pain, Gastrointestinal disorder, Throat irritation, Diarrhoea, Cough, |
||||
TREPROSTINIL, TREPROSTINIL, NINTEDANIB, VITAMIN C, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, VITAMIN E, RITUXIMAB, BUPROPION, ESOMEPRAZOLE MAGNESIUM, ERGOCALCIFEROL, OXYGEN, 0XYGEN, AMLODIPINE BESYLATE, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 454 | 26908506 |
US |
51 | 2 |
Lip swelling, Hypoaesthesia, Sneezing, Cough, |
||||
GADOBENATE DIMEGLUMINE, |
||||
| 455 | 26908710 |
US |
2 | |
Cough, Nasal congestion, Dyspnoea, Dysphonia, Device issue, Drug ineffective, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 456 | 26908753 |
GB |
61 | 1 |
Legionella infection, Pneumonia, Antimicrobial susceptibility test, Pulmonary embolism, Atrial fibrillation, Infection, Cough, |
||||
UPADACITINIB, |
||||
| 457 | 26908792 |
US |
20 | 1 |
Asthma, Cough, Asthma, Dyspnoea, Asthma, Cough, Asthma, Dyspnoea, |
||||
SALICYLIC ACID, |
||||
| 458 | 26908893 |
GB |
72 | 1 |
Lower respiratory tract infection, Product dose omission issue, Cough, Negative thoughts, |
||||
BIMEKIZUMAB, |
||||
| 459 | 26909052 |
US |
81 | 1 |
Cough, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 460 | 26909101 |
DZ |
0 | 2 |
Pyrexia, Cough, Product use issue, Off label use, |
||||
PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 461 | 26909208 |
US |
67 | 1 |
Dyspnoea, Cough, Chronic obstructive pulmonary disease, Drug ineffective, |
||||
BENRALIZUMAB, BENRALIZUMAB, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 462 | 26909210 |
US |
1 | |
Lower respiratory tract infection, Rhinovirus infection, Nasopharyngitis, Dizziness, Off label use, Cough, Ill-defined disorder, |
||||
PEGLOTICASE, PEGLOTICASE, PEGLOTICASE, |
||||
| 463 | 26909262 |
IN |
||
Sjogren^s syndrome, Drug ineffective, Haemoglobin decreased, Haemoglobin increased, Platelet count decreased, White blood cell count abnormal, Blood uric acid abnormal, Paraesthesia, Productive cough, Palpitations, Cough, Product use in unapproved indication, Blood potassium increased, Fibrosis, Platelet count increased, |
||||
RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, RUXOLITINIB, |
||||
| 464 | 26909312 |
US |
74 | 2 |
Pneumonia, Cough, |
||||
DUPILUMAB, AMOXICILLIN, PREDNISONE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, EZETIMIBE, GABAPENTIN, IRON, SITAGLIPTIN AND METFORMIN HYDROCHLORIDE, SPIRONOLACTONE, ERGOCALCIFEROL, |
||||
| 465 | 26909477 |
CN |
45 | 1 |
Small intestinal stenosis, Hyperglycaemia, Hypoproteinaemia, Cough, Dysuria, |
||||
UPADACITINIB, UPADACITINIB, ENTECAVIR, ENTECAVIR ANHYDROUS, |
||||
| 466 | 26912053 |
55 | ||
Rash, Cough, |
||||
ZANUBRUTINIB, |
||||
| 467 | 26912979 |
2 | ||
Vomiting, Nausea, Abdominal pain, Cough, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, |
||||
| 468 | 26903658 |
CN |
||
Myocardial necrosis marker increased, Pain, Headache, Pain in extremity, Abdominal pain, Chest discomfort, Palpitations, Dizziness, Neck pain, Cough, Sputum discoloured, Hyperhidrosis, Haemoptysis, Vomiting, Diarrhoea, Inappropriate schedule of product administration, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, |
||||
| 469 | 26903780 |
US |
54 | 2 |
Cough, Pain in extremity, |
||||
DUPILUMAB, |
||||
| 470 | 26903791 |
US |
70 | 2 |
Upper respiratory tract infection, Cough, Asthma, |
||||
DUPILUMAB, |
||||
| 471 | 26903848 |
US |
1 | |
Cough, |
||||
DUPILUMAB, |
||||
| 472 | 26903852 |
US |
2 | |
Sensation of foreign body, Oropharyngeal pain, Throat clearing, Cough, Pharyngeal swelling, Dysphagia, |
||||
LUMATEPERONE, LUMATEPERONE, |
||||
| 473 | 26903882 |
US |
1 | |
Vision blurred, Cough, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, FINASTERIDE, ATORVASTATIN CALCIUM, MONTELUKAST SODIUM, MONTELUKAST, |
||||
| 474 | 26903927 |
US |
75 | 2 |
Cough, Nasal congestion, Dyspnoea, Injection site pain, |
||||
DUPILUMAB, |
||||
| 475 | 26903929 |
US |
55 | 2 |
Viral upper respiratory tract infection, Nasal congestion, Cough, Tachycardia, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 476 | 26904002 |
88 | 2 | |
Chest discomfort, Cough, Rash, Dry mouth, Nausea, |
||||
NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), |
||||
| 477 | 26904112 |
63 | 1 | |
Respiratory tract congestion, Ill-defined disorder, Cough, Nasopharyngitis, |
||||
LENALIDOMIDE, |
||||
| 478 | 26904123 |
US |
39 | 1 |
Myalgia, Muscle spasms, Respiratory tract infection, Influenza, Cough, Productive cough, Conjunctivitis, Arthralgia, |
||||
DUPILUMAB, |
||||
| 479 | 26904138 |
US |
||
Cough, Incorrect product administration duration, |
||||
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, |
||||
| 480 | 26904229 |
CL |
76 | 2 |
Hepatic mass, Liver injury, Leukopenia, Azotaemia, Aortic arteriosclerosis, Hyperglycaemia, Mean cell volume increased, Mean cell haemoglobin increased, Mean cell haemoglobin concentration increased, Red blood cell sedimentation rate increased, Red blood cell morphology abnormal, Blood triglycerides increased, Basophil count increased, Monocyte count increased, Lymphocyte morphology abnormal, Liver disorder, Blood urea increased, Glomerular filtration rate decreased, Blood uric acid increased, Reticulocyte count increased, Red cell distribution width increased, Very low density lipoprotein increased, Monocyte count decreased, Neutrophil count increased, High density lipoprotein decreased, Anisocytosis, Red blood cell count decreased, Bilirubin conjugated increased, Gamma-glutamyltransferase increased, Aspartate aminotransferase increased, White blood cell count decreased, Platelet count decreased, Alanine aminotransferase increased, Blood creatinine increased, Breast calcifications, Hepatic hypertrophy, Hepatic lesion, Uterine leiomyoma, Nausea, Vomiting, Diarrhoea, Pyrexia, Cough, Dysuria, Lymphocyte count decreased, Macrocytosis, Platelet count decreased, Bone lesion, Hypoglycaemia, Respiratory tract infection, Haemoglobin decreased, Basophil count increased, Neutrophil count decreased, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, LETROZOLE, LETROZOLE TABLETS, LOSARTAN, |
||||
| 481 | 26904427 |
US |
57 | 2 |
Asthma, Cough, Rhinorrhoea, |
||||
DUPILUMAB, |
||||
| 482 | 26904428 |
US |
68 | 2 |
Cough, Headache, |
||||
DUPILUMAB, TREPROSTINIL, |
||||
| 483 | 26904490 |
CN |
72 | 1 |
Yawning, Blood pressure decreased, Palpitations, Cough, Contrast media allergy, |
||||
IODIXANOL, IODIXANOL, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 484 | 26908844 |
45 | 2 | |
Hair colour changes, Cough, |
||||
ANIFROLUMAB-FNIA, LISINOPRIL, CARIPRAZINE, MILNACIPRAN HYDROCHLORIDE, PREGABALIN, |
||||
| 485 | 26902658 |
US |
54 | 1 |
Cough, Sinus operation, |
||||
DUPILUMAB, |
||||
| 486 | 26902674 |
US |
56 | 1 |
Chronic obstructive pulmonary disease, Asthma, Cough, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 487 | 26902776 |
US |
68 | 2 |
Cough, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 488 | 26902792 |
CA |
2 | |
Flushing, Cough, Hypotension, Dizziness, Hyperhidrosis, Type III immune complex mediated reaction, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 489 | 26902912 |
US |
74 | 2 |
Cough, Vision blurred, Herpes virus infection, |
||||
DUPILUMAB, |
||||
| 490 | 26902923 |
US |
78 | 2 |
Asthma, Dyspnoea, Cough, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 491 | 26902995 |
EU |
49 | 1 |
Loss of consciousness, Nipple pain, Nausea, Injection site warmth, Syncope, Injection site rash, Headache, Injection site erythema, Tinnitus, Cough, Breast disorder, Pain, Injection site pruritus, Illness, |
||||
RAMIPRIL, INCLISIRAN, INCLISIRAN, |
||||
| 492 | 26903007 |
US |
2 | |
Incorrect dose administered, Pneumonia, Pulmonary mass, Pain, Feeling abnormal, Fall, Amnesia, Blood sodium decreased, Musculoskeletal stiffness, Hyperhidrosis, Tremor, Pain in extremity, Cough, Neck pain, Arthralgia, Decreased appetite, Nausea, Cortisol decreased, Dizziness, Presyncope, Nausea, |
||||
OSILODROSTAT, OSILODROSTAT, OSILODROSTAT, OSILODROSTAT, OSILODROSTAT, MIFEPRISTONE, MIFEPRISTONE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 493 | 26903092 |
US |
65 | 2 |
Cough, Rhinorrhoea, |
||||
DUPILUMAB, |
||||
| 494 | 26903309 |
US |
2 | |
Cough, Fatigue, Diarrhoea, Headache, Patient dissatisfaction with treatment, |
||||
TREPROSTINIL, TREPROSTINIL, NINTEDANIB, |
||||
| 495 | 26903362 |
CA |
72 | 2 |
Secretion discharge, Back pain, Blister, Dyspnoea, Lower respiratory tract infection, Pain of skin, Chest discomfort, Erythema, Scab, Asthenia, Cough, Fatigue, Gastroenteritis viral, Neurodermatitis, Chest pain, COVID-19, Malaise, Off label use, Peripheral swelling, Skin weeping, Urticaria, Depressed mood, Gastrointestinal pain, Pruritus, Skin lesion, Dermatitis atopic, Sinusitis, Cellulitis, Chills, |
||||
DONEPEZIL HYDROCHLORIDE, DUPILUMAB, DUPILUMAB, DUPILUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, DIMENHYDRINATE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 496 | 26903503 |
US |
1 | |
Acute respiratory failure, Loss of consciousness, Pulmonary fibrosis, Pulmonary hypertension, Dyspnoea at rest, Decreased appetite, Oxygen saturation decreased, Cough, Choking sensation, Memory impairment, Tremor, Retching, Oropharyngeal discomfort, Headache, Therapy partial responder, Device dislocation, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, FUROSEMIDE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, NERANDOMILAST, SIMVASTATIN, EZETIMIBE, PANTOPRAZOLE SODIUM, ERGOCALCIFEROL, SILDENAFIL CITRATE, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PIRFENIDONE, METOPROLOL SUCCINATE, OXYGEN, 0XYGEN, REVEFENACIN, FLUOROURACIL, PSYLLIUM HUSK, GABAPENTIN, |
||||
| 497 | 26903538 |
US |
||
Choking sensation, Cough, Wrong technique in product usage process, |
||||
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, |
||||
| 498 | 26903566 |
US |
||
Cough, Drug dose omission by device, Prescription drug used without a prescription, Device delivery system issue, |
||||
LEVALBUTEROL TARTRATE, |
||||
| 499 | 26897560 |
US |
1 | |
Hypertension, Oxygen saturation decreased, Aspiration, Pneumonia aspiration, Cough, Wheezing, Dyspnoea, Chest discomfort, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 500 | 26897623 |
US |
85 | 1 |
Brain injury, Cough, Dyspnoea, Cardiac arrest, Pulmonary oedema, Pleural effusion, Oxygen saturation decreased, |
||||
RISANKIZUMAB-RZAA, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30